DNMRQ — Danimer Scientific Cashflow Statement
0.000.00%
Last trade - 00:00- $1.18m
- $366.89m
- $46.68m
Annual cashflow statement for Danimer Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.004 | -8.85 | -60.1 | -180 | -155 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | -2.37 | 27.6 | 118 | 65.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.004 | -7.18 | -28.9 | -19.3 | 13.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0 | -13.8 | -63 | -61.8 | -47.3 |
| Capital Expenditures | — | -38.3 | -185 | -164 | -27.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.009 | -151 | -18 | 0.022 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -38.3 | -336 | -182 | -27.7 |
| Financing Cash Flow Items | -0.005 | 382 | -12 | -1.37 | -33.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.02 | 423 | 306 | 21.8 | 84 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.02 | 371 | -92.9 | -223 | 9.1 |